(Q28570484)

31 January 2017

title

Indanyl piperazines as melatonergic MT2 selective agents (English)

1 reference

31 January 2017

Ronald J. Mattson

1

1 reference

31 January 2017

John D. Catt

2

1 reference

31 January 2017

Daniel Keavy

3

1 reference

31 January 2017

Charles P. Sloan

4

1 reference

31 January 2017

James Epperson

5

1 reference

31 January 2017

Qi Gao

6

1 reference

31 January 2017

Donald B. Hodges

7

1 reference

31 January 2017

Lawrence Iben

8

1 reference

31 January 2017

Cathy D. Mahle

9

1 reference

31 January 2017

Elaine Ryan

10

1 reference

31 January 2017

Frank D. Yocca

11

1 reference

31 January 2017

language of work or name

English

0 references

publication date

24 March 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

31 January 2017

published in

1 reference

31 January 2017

volume

13

1 reference

31 January 2017

issue

6

1 reference

31 January 2017

page(s)

1199–1202

1 reference

Melatonin receptors: localization, molecular pharmacology and physiological significance

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Development of a presynaptic 5-HT1A antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Melatonin mediates two distinct responses in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

Pinealectomized rats entrain and phase-shift to melatonin injections in a dose-dependent manner.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900090-8

7 January 2021

10.1016/S0960-894X(03)00090-8

Identifiers

DOI

0 references

1 reference